adagrasib,Pembrolizumab
mirati,merck
['pembro']
 come on people. and others. use some critical reasoning, would you?
they only have 47 patients who have more than 1 month treatment and among those there were 16-17 ast/alt increases.
and 2 patients were forced to discontinue pembro.
why not save kras for 2l?
Into ovens and baking